Dr. Varga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4525 Cameron Valley Pkwy
Ste 3500
Charlotte, NC 28211Phone+1 704-302-8300
Education & Training
- University of Montreal Faculty of MedicineClass of 2007
Certifications & Licensure
- NC State Medical License 2021 - 2025
- MA State Medical License 2013 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis Start of enrollment: 2016 Nov 21
Publications & Presentations
PubMed
- MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma.Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry A Paul
Blood Advances. 2024-11-22 - Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial.Cindy Varga, Felix Eichinger, Viji Nair, Abhijit S Naik, Samih H Nasr
Kidney International Reports. 2024-09-01 - Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).Hamid Ehsan, Myra Robinson, Peter M Voorhees, Kristen Cassetta, Shanice Borden
Life. 2024-03-14
Journal Articles
- Beyond NEOD001 for Systemic Light-Chain AmyloidosisSuzanne Lentzsch, Cindy Varga, Blood
- High-Dose Melphalan and Stem Cell Transplantation in Systemic AL Amyloidosis in the Era of Novel Anti-Plasma Cell Therapy: A Comprehensive ReviewCindy Varga, MD, Nature
Abstracts/Posters
- The Use of Next Generation Gene Sequencing to Measure Minimal Residual Disease in Patients with AL Amyloidosis and Low Plasma Cell Burden: A Feasibility StudyCindy Varga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- In Systemic Light-Chain Amyloidosis Complete and Very Good Partial Responses Are Not Enough: Involved Free Light Chain (iFLC) Levels < 10mg/L Are Associated with Optim...Cindy Varga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia TherapyCindy Varga, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- Merrimack Valley Man Overcomes Addiction, Kidney FailureDecember 8th, 2020
- Use of Eculizumab in Transplant-Associated Thrombotic Microangiopathy in a Patient with Polycystic Kidney Disease Immediately Post–Kidney Transplant: A Case ReportAugust 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: